Business Description
MiNK Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US6036931029
Description
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -3.97 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -10.9 | |||||
| 3-Year EPS without NRI Growth Rate | -4.4 | |||||
| 3-Year FCF Growth Rate | -15.8 | |||||
| 3-Year Book Growth Rate | 35 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.74 | |||||
| 9-Day RSI | 41.57 | |||||
| 14-Day RSI | 45.01 | |||||
| 6-1 Month Momentum % | -4.76 | |||||
| 12-1 Month Momentum % | -33.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.32 | |||||
| Quick Ratio | 0.32 | |||||
| Cash Ratio | 0.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.8 | |||||
| Shareholder Yield % | 1.53 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -180.57 | |||||
| ROIC % | -661.73 | |||||
| ROC (Joel Greenblatt) % | -2230.97 | |||||
| ROCE % | -2295.77 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.21 | |||||
| EV-to-Forward-EBIT | -1.01 | |||||
| EV-to-EBITDA | -1.23 | |||||
| EV-to-FCF | -1.76 | |||||
| Earnings Yield (Greenblatt) % | -82.64 | |||||
| FCF Yield % | -50.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:INKT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MiNK Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.65 | ||
| Beta | 0 | ||
| Volatility % | 46.16 | ||
| 14-Day RSI | 45.01 | ||
| 14-Day ATR ($) | 0.074809 | ||
| 20-Day SMA ($) | 0.918458 | ||
| 12-1 Month Momentum % | -33.77 | ||
| 52-Week Range ($) | 0.75 - 3.34 | ||
| Shares Outstanding (Mil) | 34.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MiNK Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MiNK Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
MiNK Therapeutics Inc Frequently Asked Questions
What is MiNK Therapeutics Inc(INKT)'s stock price today?
The current price of INKT is $0.90. The 52 week high of INKT is $3.34 and 52 week low is $0.75.
When is next earnings date of MiNK Therapeutics Inc(INKT)?
The next earnings date of MiNK Therapeutics Inc(INKT) is 2024-05-14.
Does MiNK Therapeutics Inc(INKT) pay dividends? If so, how much?
MiNK Therapeutics Inc(INKT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers